Martin SENDZIK

Person

Belmont, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
N-azaspirocycloalkane substituted N-heteroaryl compounds and compos...
- Patent number 12,209,098
- Issue date Jan 28, 2025
- Novartis AG
- Christine Hiu-Tung Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-azaspirocycloalkane substituted N-heteroaryl compounds and compos...
- Patent number 11,952,386
- Issue date Apr 9, 2024
- Novartis AG
- Christine Hiu-Tung Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolopyrimidine compounds and uses thereof
- Patent number 11,931,363
- Issue date Mar 19, 2024
- Novartis AG
- Ho Man Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for inhibiting the activity of SHP2
- Patent number 11,905,283
- Issue date Feb 20, 2024
- Novartis AG
- Zhuoliang Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolopyrimidine compounds and uses thereof
- Patent number 11,207,325
- Issue date Dec 28, 2021
- Novartis AG
- Ho Man Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-azaspirocycloalkane substituted N-heteroaryl compounds and compos...
- Patent number 10,968,235
- Issue date Apr 6, 2021
- Novartis AG
- Christine Hiu-Tung Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for inhibiting the activity of SHP2
- Patent number 10,934,285
- Issue date Mar 2, 2021
- Novartis AG
- Zhuoliang Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolopyridine compounds and uses thereof
- Patent number 10,689,378
- Issue date Jun 23, 2020
- Novartis AG
- Ho Man Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazolepyridine compounds and uses thereof
- Patent number 10,676,479
- Issue date Jun 9, 2020
- Novartis AG
- Ho Man Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-azaspirocycloalkane substituted N-heteroaryl compounds and compos...
- Patent number 10,336,774
- Issue date Jul 2, 2019
- Novartis AG
- Christine Hiu-Tung Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for inhibiting the activity of SHP2
- Patent number 10,308,660
- Issue date Jun 4, 2019
- Novartis AG
- Zhuoliang Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and...
- Patent number 10,301,278
- Issue date May 28, 2019
- Novartis AG
- Zhuoliang Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for inhibiting the activity of SHP2
- Patent number 10,287,266
- Issue date May 14, 2019
- Novartis AG
- Zhuoliang Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolopyrimidine compounds and uses thereof
- Patent number 10,220,036
- Issue date Mar 5, 2019
- Novartis AG
- Ho Man Chan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions as RAF kinase inhibitors
- Patent number 10,167,279
- Issue date Jan 1, 2019
- Novartis AG
- Robert John Aversa
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
- Patent number 10,112,931
- Issue date Oct 30, 2018
- Novartis AG
- Thomas Raymond Caferro
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-azaspirocycloalkane substituted N-heteroaryl compounds and compos...
- Patent number 10,077,276
- Issue date Sep 18, 2018
- Novartis AG
- Christine Hiu-Tung Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-azaspirocycloalkane substituted N-heteroaryl compounds and compos...
- Patent number 9,938,295
- Issue date Apr 10, 2018
- Novartis AG
- Christine Hiu-Tung Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and...
- Patent number 9,815,813
- Issue date Nov 14, 2017
- Novartis AG
- Zhuoliang Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
- Patent number 9,688,672
- Issue date Jun 27, 2017
- Novartis AG
- Thomas Raymond Caferro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazolopyrimidine compounds and uses thereof
- Patent number 9,580,437
- Issue date Feb 28, 2017
- Novartis AG
- Ho Man Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
- Patent number 9,434,719
- Issue date Sep 6, 2016
- Novartis AG
- Thomas Raymond Caferro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hydroxamates as therapeutic agents
- Patent number 9,186,347
- Issue date Nov 17, 2015
- PHARMACYCLICS LLC
- Erik J. Verner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
- Patent number 8,957,068
- Issue date Feb 17, 2015
- Novartis AG
- Thomas Raymond Caferro
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and uses thereof
- Patent number 8,865,732
- Issue date Oct 21, 2014
- Novartis AG
- Zilin Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hydroxamates as therapeutic agents
- Patent number 8,779,171
- Issue date Jul 15, 2014
- Pharmacyclics, Inc.
- Erik J. Verner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaryl compounds and their uses
- Patent number 8,778,951
- Issue date Jul 15, 2014
- Novartis AG
- Paul A. Barsanti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
6-O-substituted benzoxazole and benzothiazole compounds and methods...
- Patent number 8,710,048
- Issue date Apr 29, 2014
- Novartis AG
- James C. Sutton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds and their uses
- Patent number 8,415,381
- Issue date Apr 9, 2013
- Novartis AG
- Paul A. Barsanti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hydroxamates as therapeutic agents
- Patent number 8,389,570
- Issue date Mar 5, 2013
- Pharmacyclics, Inc.
- Erik J. Verner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPLEMENT FACTOR B INHIBITORS AND USES THEREOF
- Publication number 20250223277
- Publication date Jul 10, 2025
- Novartis AG
- Lara C. CZABANIUK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIROCYCLIC PIPERIDINYL DERIVATIVES AS COMPLEMENT FACTOR B INHIBITO...
- Publication number 20250115572
- Publication date Apr 10, 2025
- Novartis AG
- Christopher M. ADAMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF ERK
- Publication number 20250092036
- Publication date Mar 20, 2025
- Novartis AG
- Erich W. BAUM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FATTY ACID-BIFUNCTIONAL DEGRADER CONJUGATES AND THEIR METHODS OF USE
- Publication number 20240216513
- Publication date Jul 4, 2024
- Novartis AG
- Claire Adcock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF
- Publication number 20240216378
- Publication date Jul 4, 2024
- Novartis AG
- Ho Man CHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2
- Publication number 20240199609
- Publication date Jun 20, 2024
- Novartis AG
- Zhuoliang CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF
- Publication number 20230033320
- Publication date Feb 2, 2023
- Novartis AG
- Ho Man CHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOS...
- Publication number 20220396585
- Publication date Dec 15, 2022
- Novartis AG
- Christine Hiu-Tung Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRD9 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE
- Publication number 20220315578
- Publication date Oct 6, 2022
- Novartis AG
- Xin CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOS...
- Publication number 20220073537
- Publication date Mar 10, 2022
- Novartis AG
- Christine Hiu-Tung Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOS...
- Publication number 20210371429
- Publication date Dec 2, 2021
- Novartis AG
- Christine Hiu-Tung Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2
- Publication number 20210300919
- Publication date Sep 30, 2021
- Novartis AG
- Zhuoliang CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF
- Publication number 20200323859
- Publication date Oct 15, 2020
- Novartis AG
- Ho Man CHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOS...
- Publication number 20200181168
- Publication date Jun 11, 2020
- Novartis AG
- Christine Hiu-Tung Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2
- Publication number 20200002330
- Publication date Jan 2, 2020
- Novartis AG
- Zhuoliang CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOLEPYRIDINE COMPOUNDS AND USES THEREOF
- Publication number 20190233426
- Publication date Aug 1, 2019
- Novartis AG
- Ho Man CHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLOPYRIDINE COMPOUNDS AND USES THEREOF
- Publication number 20190202828
- Publication date Jul 4, 2019
- Novartis AG
- Ho Man CHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF
- Publication number 20190142837
- Publication date May 16, 2019
- Novartis AG
- Ho Man CHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2
- Publication number 20180251471
- Publication date Sep 6, 2018
- Zhuoliang Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOS...
- Publication number 20180201623
- Publication date Jul 19, 2018
- Novartis AG
- Christine Hiu-Tung Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2
- Publication number 20180186770
- Publication date Jul 5, 2018
- Zhuoliang Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS
- Publication number 20180170917
- Publication date Jun 21, 2018
- Novartis AG
- Robert John AVERSA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1-(TRIAZIN-3-YL/PYRIDAZIN-3-YL)-PIPER(-AZINE)IDINE DERIVATIVES AND...
- Publication number 20180065949
- Publication date Mar 8, 2018
- Novartis AG
- Zhuoliang Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH
- Publication number 20180051015
- Publication date Feb 22, 2018
- Novartis AG
- Thomas Raymond CAFERRO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF
- Publication number 20170348312
- Publication date Dec 7, 2017
- Ho Man CHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOS...
- Publication number 20170015680
- Publication date Jan 19, 2017
- Novartis AG
- Christine Hiu-Tung Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1-(TRIAZIN-3-YL/PYRIDAZIN-3-YL)-PIPER(-AZINE)IDINE DERIVATIVES AND...
- Publication number 20170001975
- Publication date Jan 5, 2017
- Novartis AG
- Zhuoliang Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH
- Publication number 20160318915
- Publication date Nov 3, 2016
- Novartis AG
- Thomas Raymond CAFERRO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF
- Publication number 20160176882
- Publication date Jun 23, 2016
- Ho Man CHAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS
- Publication number 20150320718
- Publication date Nov 12, 2015
- Pharmacyclics, Inc.
- Erik J. VERNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Martin SENDZIK

Person

Patents Grantslast 30 patents

N-azaspirocycloalkane substituted N-heteroaryl compounds and compos...

N-azaspirocycloalkane substituted N-heteroaryl compounds and compos...

Triazolopyrimidine compounds and uses thereof

Compounds and compositions for inhibiting the activity of SHP2

Triazolopyrimidine compounds and uses thereof

N-azaspirocycloalkane substituted N-heteroaryl compounds and compos...

Compounds and compositions for inhibiting the activity of SHP2

Triazolopyridine compounds and uses thereof

Imidazolepyridine compounds and uses thereof

N-azaspirocycloalkane substituted N-heteroaryl compounds and compos...

Compounds and compositions for inhibiting the activity of SHP2

1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and...

Compounds and compositions for inhibiting the activity of SHP2

Triazolopyrimidine compounds and uses thereof

Compounds and compositions as RAF kinase inhibitors

3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH

N-azaspirocycloalkane substituted N-heteroaryl compounds and compos...

N-azaspirocycloalkane substituted N-heteroaryl compounds and compos...

1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and...

3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH

Triazolopyrimidine compounds and uses thereof

3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH

Hydroxamates as therapeutic agents

3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH

Heterocyclic compounds and uses thereof

Hydroxamates as therapeutic agents

Heteroaryl compounds and their uses

6-O-substituted benzoxazole and benzothiazole compounds and methods...

Heteroaryl compounds and their uses

Hydroxamates as therapeutic agents

Patents Applicationslast 30 patents

COMPLEMENT FACTOR B INHIBITORS AND USES THEREOF

SPIROCYCLIC PIPERIDINYL DERIVATIVES AS COMPLEMENT FACTOR B INHIBITO...

COMPOUNDS AND COMPOSITIONS FOR MODULATING THE ACTIVITY OF ERK

FATTY ACID-BIFUNCTIONAL DEGRADER CONJUGATES AND THEIR METHODS OF USE

TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF

N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOS...

BRD9 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE

N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOS...

N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOS...

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF

N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOS...

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

IMIDAZOLEPYRIDINE COMPOUNDS AND USES THEREOF

TRIAZOLOPYRIDINE COMPOUNDS AND USES THEREOF

TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOS...

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS

1-(TRIAZIN-3-YL/PYRIDAZIN-3-YL)-PIPER(-AZINE)IDINE DERIVATIVES AND...

3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH

TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF

N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOS...

1-(TRIAZIN-3-YL/PYRIDAZIN-3-YL)-PIPER(-AZINE)IDINE DERIVATIVES AND...

3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH

TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF

NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS